KETAMINE HYDROCHLORIDE INJECTION

The Defense Logistics Agency awarded a delivery order under solicitation SPE2D926F7430 to CARDINAL HEALTH, INC. (CAGE 00E55) for the supply of KETAMINE HYDROCHLORIDE INJECTION, identified by NSN 6505013391909, with a total contract value of $80.66. The award was issued on July 18, 2026, and is linked to the parent contract SPE2DX25D8022, suggesting this is a routine or replenishment order under an existing indefinite-delivery vehicle. The product is a controlled pharmaceutical item requiring strict compliance with federal regulations, including FDA requirements, United States Pharmacopeia standards, and current Good Manufacturing Practices. While no specific delivery schedule, FOB terms, or place of performance is provided, the nature of the item implies that packaging and labeling must conform to DoD standards such as MIL-STD-129 for marking and MIL-STD-2073 for preservation, ensuring traceability via barcoding, presence of lot and expiration dates, and proper handling controls for pharmaceutical integrity. The awardee, CARDINAL HEALTH, INC., is a registered federal supplier, but no socioeconomic status, size certification, or affirmative representations are disclosed in the available metadata. No details on inspection criteria, contract administration, payment methods, or point of contact information are present, nor are any contract clauses, special requirements, or evaluation factors accessible due to document processing failures and content restrictions. The contract lacks explicit terms for performance period, invoicing methodology, or contracting officer representative details, indicating this is a minimal-order transaction likely processed through automated or streamlined channels. The award appears to be based on price alone, though the basis of award is not formally stated, and the low value suggests a sample order, emergency replenishment, or limited-use requirement within a larger pharmaceutical supply chain managed by the Department of Defense.